This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Earnings Preview: Orion Engineered Carbons (OEC) Q2 Earnings Expected to Decline
by Zacks Equity Research
Orion Engineered Carbons (OEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Orion Engineered Carbons (OEC) Q1 Earnings Expected to Decline
by Zacks Equity Research
Orion Engineered Carbons (OEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Orion Engineered Carbons (OEC) a Suitable Value Pick Now?
by Zacks Equity Research
Let's see if Orion Engineered Carbons, S.A. (OEC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Orion Engineered Carbons (OEC) Q3 Earnings Lag Estimates
by Zacks Equity Research
Orion Engineered Carbons (OEC) delivered earnings and revenue surprises of -1.92% and 2.18%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Orion Engineered Carbons (OEC) Q3 Earnings Preview: What to Expect
by Zacks Equity Research
Orion Engineered Carbons (OEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
International Flavors & Fragrances Completes Frutarom Buy
by Zacks Equity Research
Following the completion of the Frutarom acquisition, International Flavors & Fragrances, Inc. (IFF) now boasts a differentiated portfolio and an expanded customer base.
Should Value Investors Pick Orion Engineered Carbons (OEC) Stock?
by Zacks Equity Research
Is Orion Engineered Carbons (OEC) a great pick from the value investor's perspective right now? Read on to know more.
Vale (VALE) Scales 52-Week High: What's Driving the Rally?
by Zacks Equity Research
Rise in global steel production, demand for higher iron ore grade and increased liquidity is likely to strengthen Vale SA's (VALE) competency, going forward.
Orion Engineered Carbons (OEC) Q2 Earnings Top Estimates
by Zacks Equity Research
Orion Engineered Carbons (OEC) delivered earnings and revenue surprises of 30.77% and -2.29%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Cabot (CBT) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Cabot (CBT) is likely to see year-over-year revenue growth in Q3.
International Flavors (IFF) Q2 Earnings: What's in Store?
by Zacks Equity Research
International Flavors (IFF) anticipates gaining from acquired businesses as well as its multi-year productivity program. However, inflated material costs will restrain margins.
Mosaic (MOS) to Post Q2 Earnings: What's in the Cards?
by Anindya Barman
Strong expected segment performance is likely to support Mosaic's (MOS) Q2 results.
Westlake Chemical's (WLK) Q2 Earnings: Is a Beat Likely?
by Zacks Equity Research
Westlake Chemical (WLK) revenues are projected to increase on benefits from acquisition.
What's in the Cards for WestRock (WRK) this Earnings Season?
by Zacks Equity Research
Despite cost headwinds, favorable demand, price and mix trends across its paper and packaging businesses will aid WestRock's (WRK) earnings performance in the third quarter.
DowDuPont (DWDP) Q2 Earnings: Is Another Beat in Store?
by Anindya Barman
DowDuPont (DWDP) is likely to gain from continued strong demand, higher pricing and cost synergies in Q2.
Univar (UNVR) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Most segments of Univar (UNVR) are expected to witness a year-over-year improvement in Q2 revenues.
U.S. Steel (X) Warms Up to Q2 Earnings: What's in the Cards?
by Anindya Barman
U.S. Steel (X) is likely to gain from higher steel pricing in the second quarter.
FMC Corp (FMC) Q2 Preview: Will the Earnings Streak Continue?
by Anindya Barman
Strong segment performance is expected to support FMC Corp.'s (FMC) earnings in Q2.
Arconic (ARNC) Q2 Earnings Preview: What's in the Cards?
by Anindya Barman
Arconic (ARNC) is expected to gain from its cost reduction and productivity improvement actions in Q2.
Praxair (PX) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Improvement in industrial activities in the United States bodes well for Praxair (PX) in the second quarter. However, rising costs will constrain margins.
International Paper (IP) Q2 Earnings: What Lies in Store?
by Zacks Equity Research
International Paper's (IP) restructuring initiatives and favorable demand trends bode well for growth in the second quarter.
What's in the Cards for CVR Partners (UAN) in Q2 Earnings?
by Anindya Barman
While turnaround at the Coffeyville plant may affect CVR Partners' (UAN) Q2 volumes, it is likely to gain from improved pricing.
Can Eastman Chemical (EMN) Sustain Earnings Streak in Q2?
by Anindya Barman
While Eastman Chemical (EMN) faces headwinds from higher raw materials costs, its high margin products and productivity actions are likely to support its Q2 earnings.
The Zacks Analyst Blog Highlights: ArcelorMittal, Fresenius Medical Care AG, Orion Engineered Carbons S.A., Royal Dutch Shell and Globant S.A.
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ArcelorMittal, Fresenius Medical Care AG, Orion Engineered Carbons S.A., Royal Dutch Shell and Globant S.A.
ECB Sticks to Accommodative Monetary Stance: 5 Top Picks
by Nalak Das
The ECB kept its main refinancing rate, and rates on marginal lending facility and deposit facility at unchanged at 0%, 0.258% and -0.4%, respectively.